Minutes of networking breaks
Two 50-minute breaks make room for the conversations that short coffee queues cannot.
WORLD AI READY / AN ESCOM EVENTS CONFERENCEAI for Drug Discovery
AI for Drug Discovery
Asia 2027.
From promising predictions to better drug decisions.
Biological evidence. Better molecules. More credible translation.
Conceptual scientific artwork · Not a representation of an actual experiment
THE NEXT SCIENTIFIC DECISIONA prediction is the start.
A prediction is the start.
Evidence is the next step.
AI for Drug Discovery Summit Asia connects pharmaceutical and biotechnology teams with researchers, computational innovators and translational experts. The programme examines where AI can change a drug discovery decision, from target selection and molecular design to experimental validation and development handover. Rather than treating a model output as a breakthrough, sessions ask what evidence is needed, what failure looks like and how multidisciplinary teams can make the next decision with greater confidence.
Leave with a practical framework for evaluating AI drug discovery partners, validating workflows and building more credible translation plans.
Minutes per company demo
One workflow, clear evidence and a strict handover. Follow up with the people who matter.
Decision-led panels
Discussion around practical trade-offs, with curated questions and multiple perspectives.
01 / THE RESEARCH AGENDAAcross the pipeline.
Across the pipeline.
Grounded in evidence.
Follow the decisions that connect a computational hypothesis to an experimentally supported discovery programme.
Target discovery and biological validation
Separate a plausible target hypothesis from evidence of causal and patient-relevant biology.
Generative chemistry and molecular design
Assess molecular novelty alongside synthesizability, selectivity and medicinal chemistry judgement.
Multimodal biological data and foundation models
Connect modalities without hiding data quality, representativeness or leakage risks.
ADMET, developability and uncertainty estimation
Make uncertainty visible when prioritising candidates and evaluating failure modes.
Wet-lab validation and closed-loop discovery
Use prospective assays and negative results to improve the next discovery decision.
Translational evidence and development handover
Build the evidence package needed for a responsible development handover.
Data governance, intellectual property and partnering
Create clear rules for data access, ownership and collaboration.
Building and buying AI discovery capabilities
Evaluate capability gaps, partner claims and the practical economics of adoption.
02 / DAY 2 PROGRAMMEA day designed
A day designed
for useful exchange.
Programme proposal. All times are Singapore time, UTC+8. Session topics and sequencing may change before launch.
16 programme sessions
Registration and coffee
Reconnect with Day 1 delegates and meet the drug discovery community.
Opening perspective
What evidence makes AI useful in a drug discovery programme?
Research Spotlight · From model to biological evidence
How to connect computational hypotheses with testable biology and appropriate experimental controls.
Decision Panel · The target is not the treatment
Target selection, causal biology, patient relevance and the evidence needed to commit resources.
Networking break
50 minutes for scientific discussions, introductions and refreshments.
Innovation Demos · The discovery decision stack
Four companies, ten minutes each: targets, molecules, assays and decision support. No standalone Q&A.
Decision Panel · Generative chemistry meets medicinal chemistry
Novelty, synthesizability, selectivity, ADMET and the judgement that still matters.
Evidence briefing · A vendor evaluation checklist
Questions to ask about data leakage, baselines, prospective tests, uncertainty and reproducibility.
Lunch and open networking
A 60-minute lunch break, included in the delegate pass.
Decision Panel · The wet lab is the test
Assay quality, negative results, automation and the design of closed-loop discovery programmes.
Innovation Demos · Translation in practice
Three companies, ten minutes each. Show experimental feedback and the next development decision. No standalone Q&A.
Networking break
50 minutes for partnership conversations and technical follow-up.
Decision Panel · Building a credible route to development
Translational evidence, reproducibility, data governance and expectations at development handover. Not a regulatory approval clinic.
Working Roundtables · Build, buy or partner?
Choose a discussion on data access, platform evaluation, pharma–biotech partnering or translational strategy.
Private networking sessions
Opt-in meetings for research and commercial collaboration. No guaranteed investor, regulator or pharma appointment.
Closing synthesis
A practical checklist for the next experiment, partnership and investment decision.
Company demos are 10 minutes each with no standalone Q&A. Academic Research Spotlights have a separate editorial format. Panel questions are curated by the moderator.
LESS PRESENTING. MORE PROGRESS.Choose the format
Choose the format
that fits the evidence.
We welcome research leaders, scientific founders, pharma and biotech practitioners, laboratory teams and implementation leaders. Propose a research spotlight, panel contribution or ten-minute Innovation Demo. Submissions will be assessed for evidence, relevance and practical value. A commercial relationship does not guarantee an editorial speaking slot.
Prepare a speaker proposalResearch Spotlight
20 minutesAn academic or non-company scientific contributor explains one important advance, its evidence and limitations. All company-affiliated solo presentations are limited to ten-minute Innovation Demos.
Innovation Demo
10 minutes per companyShow one use case, one workflow and measurable evidence. Strict handover to the next presenter, with no standalone Q&A. Continue the conversation during networking.
Decision Panel
40 minutesA moderated conversation built around a real decision, conflicting evidence and practical trade-offs. Audience questions are curated within the panel.
Working Roundtables
30 minutesSmall-group discussion around a defined challenge, producing a short list of next actions rather than another slide presentation.
03 / THE PEOPLE IN THE ROOMDiscovery is a
Discovery is a
team discipline.
Designed for the teams who must connect biology, chemistry, data, experiments and partnerships. No single discipline can do this alone.
Pharmaceutical and biotechnology companies
Discovery heads, computational chemistry and biology leaders, medicinal chemists, translational teams and business development directors
Universities, research institutes and hospitals
Principal investigators, chemical biologists, bioinformaticians, experimental scientists and clinician-scientists
AI discovery and platform companies
AI-native biotech, molecular design, biological modelling, data platform and scientific software teams
Research service and infrastructure providers
CROs, laboratory automation, assay providers, compute, cloud and research data specialists
Public agencies, investors and ecosystem builders
Regulatory science, research funding, innovation agencies, life-sciences investors and technology-transfer professionals
Academic research leadershipExperimental validationIndustry implementationResearch policy and translation
04 / DELEGATE PASSESOne focused day.
One focused day.
Or the full picture.
Two complementary conferences. Choose the day most relevant to your work, or connect scientific discovery with drug discovery across both days.
USD 390
Attend AI for Drug Discovery Summit Asia on day 2.
- Lunch on each booked day
- Conference materials made available by participating speakers
- Morning and afternoon networking sessions
- Access to private networking sessions on booked days, subject to scheduling and participant consent
USD 590
Attend AI for Science Asia and AIDD Asia. USD 190 less than two separate one-day passes.
- Both conference programmes
- Lunch on both booked days
- Available conference materials from both days
- Networking and private sessions on both days, subject to scheduling and consent
Proposed delegate pricing. Registration is not yet open. Any applicable taxes and booking terms will be stated before payment. Travel and accommodation are excluded. Private sessions do not guarantee a meeting with any named person.
MEET THE PEOPLE BUILDING WHAT IS NEXTPut your work
Put your work
in the conversation.
Sponsorship is available alongside paid delegate passes. Show a relevant capability, support useful discussion and build relationships with consent.
Founding Partner
A tailored presence across the two-day programme, with clearly disclosed branding, a demonstration opportunity subject to programme review, and opt-in networking participation. Any demonstration position is subject to editorial approval and shared programme capacity.
Day Partner
Focused visibility with the scientific discovery or drug discovery audience, a demonstration position and a compact meeting area, subject to venue confirmation. Any demonstration position is subject to editorial approval and shared programme capacity.
Innovation Demonstrator
A ten-minute demonstration and a space for follow-up conversations. Show practical evidence rather than a long product presentation. Any demonstration position is subject to editorial approval and shared programme capacity.
Packages, availability and pricing are by proposal. No sponsor, partner or institutional endorsement is confirmed. Delegate details are not sold or shared without appropriate consent. Demonstration slots are limited to seven per day across all sponsorship tiers, subject to programme review and availability.
Knowledge and community partnerships
A non-commercial collaboration route for research institutions, professional communities and relevant associations. Every partnership requires separate agreement.
Discuss a partnershipYOUR NEXT STEPHelp shape
Help shape
the first edition.
Registration is not yet open. Email Escom Events’ organiser contact to express interest, propose a contribution or discuss sponsorship. Please name AI for Drug Discovery Summit Asia Singapore 2027 in your enquiry.
This preview does not collect personal information or process payments. The organiser will confirm the official registration route and terms before booking opens.
These links open an email draft to mike.li@escom-events.com. Nothing is sent until you review and send it.
05 / PRACTICAL INFORMATIONKnow before
Know before
you make plans.
Clear facts, visible status and no assumptions about confirmations. Last reviewed 30 October 2026.
When and where will the conference take place?
2 June 2027 · proposed in Singapore. Singapore venue to be confirmed. The programme, exact dates and venue remain proposed until the organiser publishes confirmation. Please do not book non-refundable travel on this basis.
How much are the passes?
The proposed price is USD 390 for one conference day or USD 590 for both AI for Science Asia and AIDD Asia. Registration is not yet open. Applicable taxes, payment terms and cancellation conditions will be stated before booking.
What is included in a delegate pass?
Admission on booked days, lunch, participating speakers’ available conference materials, morning and afternoon networking, and access to private networking sessions subject to scheduling and mutual consent. Travel and accommodation are not included.
Can I attend one day only?
Yes. Select the one-day pass for AI for Drug Discovery Summit Asia, or choose the two-day pass to attend both conferences. A one-day pass does not include the other conference day.
How can I apply to speak?
Prepare your name, role, organisation, proposed session format, talk title, 150-word abstract, relevant evidence and commercial disclosures. Contact Escom Events and state the conference name. Applications are assessed on relevance and evidence; a submission does not guarantee acceptance.
Are any speakers or university partnerships confirmed?
No speaker or institutional partnership is confirmed in this proposal. Names in the separate organiser research pack are invitation targets, not announced speakers. The conferences are independently organised by Escom Events under World AI Ready.
Will every company receive a long speaking slot?
No. Company Innovation Demos are ten minutes each, with a strict handover and no standalone Q&A. Technical and commercial follow-up belongs in the networking breaks. Moderated panels can include curated audience questions.
Can the conference guide answer questions using AI?
This source preview includes a local conference guide that retrieves approved information. It does not use a live language model. An optional server-side AI adapter is included for an authorised operator to configure before launch. Do not enter sensitive personal or research information.
Is AIDD Asia part of a government programme?
No. This is an independent Escom Events conference proposal. It is not the A*STAR AI in Drug Discovery (AIDD) programme and does not imply government, university or other institutional endorsement.
TWO DAYS. TWO DISTINCT LENSES.
Explore Day 1 AI for Science Asia
Also interested in the wider scientific AI landscape? Join AI for Science Asia on Day 1 to explore research models, data, laboratory automation and cross-disciplinary discovery.